Publikationen, an denen er mitarbeitet Gabriela Rodríguez Macías (18)

2023

  1. Novel Candidate loci and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing

    Cancers, Vol. 15, Núm. 3

  2. Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy

    Cancers, Vol. 15, Núm. 12

2022

  1. Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility

    International Journal of Hematology, Vol. 115, Núm. 1, pp. 61-68

2021

  1. Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition

    Molecular Oncology, Vol. 15, Núm. 9, pp. 2273-2284

  2. Genetic biomarkers identify a subgroup of high-risk patients within low-risk NPM1-mutated acute myeloid leukemia

    Leukemia and Lymphoma, Vol. 62, Núm. 5, pp. 1178-1186

  3. Next generation cytogenetics in myeloid hematological neoplasms: Detection of cnvs and translocations

    Cancers, Vol. 13, Núm. 12

2020

  1. A retrospective cohort of invasive fusariosis in the era of antimould prophylaxis

    Medical Mycology, Vol. 58, Núm. 3, pp. 300-309

  2. COVID-19 coagulopathy: An in-depth analysis of the coagulation system

    European Journal of Haematology, Vol. 105, Núm. 6, pp. 741-750

  3. Exome sequencing reveals heterogeneous clonal dynamics in donor cell myeloid neoplasms after stem cell transplantation

    Haematologica

2019

  1. Methotrexate-induced subacute neurotoxicity surrounding an ommaya reservoir in a patient with lymphoma

    American Journal of Case Reports, Vol. 20, pp. 1002-1005

  2. Next-generation sequencing improves diagnosis, prognosis and clinical management of myeloid neoplasms

    Cancers, Vol. 11, Núm. 9

2018

  1. Donor Cell–Derived Hematologic Neoplasms after Hematopoietic Stem Cell Transplantation: A Systematic Review

    Biology of Blood and Marrow Transplantation, Vol. 24, Núm. 7, pp. 1505-1513

  2. Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib

    Oncotarget, Vol. 9, Núm. 47, pp. 28474-28485

  3. Whole-exome sequencing reveals acquisition of mutations leading to the onset of donor cell leukemia after hematopoietic transplantation: a model of leukemogenesis

    Leukemia, Vol. 32, Núm. 8, pp. 1822-1826

2016

  1. Role of drug transport and metabolism in the chemoresistance of acute myeloid leukemia

    Blood Reviews, Vol. 30, Núm. 1, pp. 55-64

2013

  1. Graft-versus-tumor effect after allogeneic stem cell transplantation in HIV-positive patients with high-risk hematologic malignancies

    AIDS Research and Human Retroviruses, Vol. 29, Núm. 10, pp. 1340-1345

  2. Mutation of the NPM1 gene contributes to the development of donor cell-derived acute myeloid leukemia after unrelated cord blood transplantation for acute lymphoblastic leukemia

    Human Pathology, Vol. 44, Núm. 8, pp. 1696-1699

2011

  1. Haploidentical bone marrow transplantation with post-grafting cyclophosphamide: Multicenter experience with an alternative salvage strategy

    Leukemia